Certara Inc. (CERT): Price and Financial Metrics
CERT Price/Volume Stats
| Current price | $10.71 | 52-week high | $19.87 |
| Prev. close | $10.55 | 52-week low | $9.41 |
| Day low | $10.51 | Volume | 3,240,100 |
| Day high | $11.05 | Avg. volume | 852,739 |
| 50-day MA | $10.82 | Dividend yield | N/A |
| 200-day MA | $13.91 | Market Cap | 1.72B |
CERT Stock Price Chart Interactive Chart >
Certara Inc. (CERT) Company Bio
Certara, Inc. engages in the provision of software and technology enables services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Princeton, NJ.
CERT Price Returns
| 1-mo | 9.62% |
| 3-mo | -1.74% |
| 6-mo | -21.42% |
| 1-year | -39.63% |
| 3-year | -63.07% |
| 5-year | N/A |
| YTD | -39.11% |
| 2023 | 9.46% |
| 2022 | -43.46% |
| 2021 | -15.72% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...